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Background/aim: Biofilm formation is a major determinant factor in the development of urinary tract infections (UTIs) by
uropathogenic Escherichia coli (UPEC). Several adhesion factors are involved in attachment of bacterial cells to the urinary tract and
biofilm development.
Materials and methods: The possible relationship between different adhesion factor genes (AFGs) and biofilm formation among UPEC
isolates was investigated. Prevalence of different AFGs including fimA, fimH, papAH, papC, papEF, sfa-S, foc/G, and bmaE and their
association to biofilm formation were investigated. Phenotypic expression of type 1 and P fimbriae was also investigated.
Results: Our results showed that 84% of UPEC were moderate to strong biofilm producers. Prevalence of the type 1 and P fimbriae
associated genes (fimA, fimH, papEF, papC) as well as the F1C fimbriae gene (foc/G) did not show a difference among different biofilmproducing groups, while higher prevalence of papAH, bmaE (M fimbriae), and sfaS (S-fimbriae) was observed for the strains producing
moderate to strong biofilms. Phenotypic expression of type 1 fimbriae was associated with biofilm formation, while no association was
observed for P fimbriae.
Conclusion: Different AFGs (especially M and S fimbria) and their expression levels affect the biofilm formation ability of UPEC.
Key words: Biofilm, virulence factors, Escherichia coli, urinary tract infections

1. Introduction
Urinary tract infection (UTI) is regarded as a serious
worldwide health threat. Uropathogenic Escherichia coli
(UPEC) is the predominant cause of community-acquired
and nosocomial UTIs (1,2). The ability of bacteria to
persist and grow in a biofilm seems to be the major
factor for pathogenesis and therapeutic failure. Biofilm
formation by UPEC is considered a determinant factor in
long-term persistence of bacterial cells in the urinary tract
and causing inflammatory reactions associated with UTIs
(3,4). Furthermore, increased drug resistance among the
strains associated with biofilm could significantly increase
the difficulty of treatment.
Biofilm formation consists of initial bacterial
adherence to the surface, followed by multiplication and
production of extracellular polymeric matrix, which cause
cell aggregation (5). UPEC strains can produce a variety
of adhesions for attachment to solid surfaces and biofilm
formation. Type 1 fimbriae, which may promote bacterial
adhesion and biofilm formation, recognize mannoseoligosaccharides naturally presented on glycoprotein
molecules of the host cell surface. Type 1 fimbriae are
* Correspondence: salehzadeh@iaurasht.ac.ir
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encoded by the fim gene cluster and consist of a major
protein, FimA, associated with ancillary proteins FimF
and FimG and the adhesion protein FimH. P fimbriae are
expressed by UPEC and are strongly associated with the
ability of the bacteria to colonize the kidney and cause
pyelonephritis. The pap gene cluster consists of 11 genes
encoding the main component of the fimbria rod (PapA),
papEF, which encode adaptor subunits, and a terminal
adhe
sion PapG (1). M fimbria, which is encoded by
bmaE, recognizes blood group M-specific determinants
of glycophorin A and has been reported to be associated
with UTIs. The S fimbriae are mannose-resistant
adhesions, encoded by the sfa operon of UPEC. The
presence of S fimbria is also correlated with pathogenicity
of E. coli strains. F1C fimbria has been described as a
nonhemagglutinating adherence factor and is expressed
by pathogenic E. coli strains. A cluster of eight genes (foc)
is necessary for the biogenesis of F1C fimbriae (1,6).
Epidemiological studies suggest these adhesion factors
to be associated with UTIs (1,2–7). However, few studies
investigated the association between adhesion factor genes
(AFGs) and biofilm formation potential of UPEC. Thus,
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the present study was conducted to investigate the possible
association between AFGs and biofilm formation among
UPEC strains.
2. Materials and methods
2.1. Bacterial isolates
In this study 100 UPEC isolates were collected from patients
presenting to clinical laboratories in the city of Rasht
(Iran) during January to July 2016. Bacterial identification
was performed by conventional biochemical methods and
all the isolates were stored at –70 °C in tryptic soy broth
(TSB) containing 20% glycerol for subsequent analysis.
2.2. In vitro biofilm assay
The biofilm formation assay was performed in triplicate
in 96-well microtiter plates, according to the method
described previously with some modifications (8).
Briefly, isolated strains were grown overnight at 37 °C
in Luria broth (LB) medium. The optical density at 600
nm (OD600) of the culture was adjusted to 1.0 and the
cultures were then diluted 1:100 in fresh LB. Then 100 µL
of the diluted cultures was added to each well. The plates
were incubated at 37 °C for 48 h under static condition.
Following incubation, the plates were washed three times
using sterile phosphate buffered saline (PBS) and 125 µL
of 0.1% crystal violet solution was added to the wells. The
plates were incubated for 15 min at room temperature
and washed with PBS three times. Biofilm formation
ability could be assessed based on color intensity. In order
to quantify biofilm formation ability, the plates were left
a few hours to dry and then 125 µL of 30% acetic acid
was added to solubilize the dye. Finally, the OD550 was
recorded using a microplate reader (Bio-Rad, USA) and
the strains were classified into two groups including no or
weak biofilm producers (Group I) and moderate to strong
biofilm producers (Group II) according to their OD value
(9). Biofilm formation was scored as follows:
Strong biofilm (S) = OD ≥ 0.3, Moderate biofilm (M)
= 0.2 ≤ OD ≤ 0.299, Weak biofilm (W) = 0.1 ≤ OD ≤
0.199, Negative (N) = OD < 0.1. The negative control wells
contained broth only and E. coli ATCC 10798 was used as
positive control (10).
2.3. Genotypic detection of AFGs
All UPEC isolates were screened for the presence of
different AFGs by polymerase chain reaction (PCR) assay.
Prevalence of the genes corresponding to the following
adhesion factors was investigated: P fimbria associated
genes (papAH, papC, and papEF), S fimbria (sfaS), F1C
fimbria (foc/G) and M blood group antigen-specific M
fimbria (bmaE). In addition, the mannose specific type 1
fimbria genes including fim A and fim H were targeted.
DNA extraction was performed using a CinnaGen
DNA extraction kit according to the manufacturer’s
instructions. The master mix for the PCR was prepared as

follows: 3 μL of 10X PCR buffer, 3 μL of 25 mM MgCl2, 3
μL of 10 mM dNTP mix, 0.5 μL of Taq DNA polymerase,
9.5 μL of Milli-Q water, and 1 μL of each of the forward
and reverse primers. Finally, 4 µL of each DNA template
was added to the corresponding tubes to make up the final
reaction volume of 25 μL. Amplification of papAH, sfaS,
bmaE, and foc/G genes was performed using multiplexPCR. The PCR primers and condition for each gene are
presented in Tables 1 and 2. Finally, PCR products were
mixed with 3 µL of PowerLoad DNA stain and were visible
after electrophoresis in a 1% agarose gel in TBE buffer and
under UV illumination. In order to ensure the accuracy
of the PCR products, the amplified genes were sequenced,
submitted to GenBank (NCBI), and blasted with other
published sequences from the GenBank database. The
aggregate AFG score was also defined as the median
number of the eight investigated AFGs detected among
UPEC isolates.
2.4. Phenotypic detection of type 1 and P fimbriae
Expression of type 1 fimbria was evaluated by mannose
sensitive agglutination assay. Briefly, a drop of 0.5%
suspension of Saccharomyces cerevisiae cells was mixed
with and one without a drop of 2% mannose solution.
UPEC were grown overnight at 37 °C in LB broth and 5
µL of bacterial suspension (approximately 106 CFU/mL)
was added to the drops. The isolates were interpreted as
positive for type 1 fimbria when showing precipitation
with yeast cells and no precipitation with yeast in the
presence of mannose (2).
To detect P fimbria, UPEC were grown overnight
at 37 °C in LB agar and 5 µL of bacterial suspension
(approximately 106 CFU/mL) was added to a drop of O
type human RBCs suspension (8% v/v) on a slide and
monitored for hemagglutination (11).
2.5. Statistical analysis
The chi-square test was used to establish the results’
significance and P values of <0.05 were considered
statistically significant.
3. Results
3.1. Biofilm formation
Biofilm formation capability of the UPEC isolates was
investigated using microtiter plates. Our results showed
that 36 isolates were strong biofilm producers, while 48
and 10 isolates were moderate and weak biofilm producers,
respectively. In addition, six UPEC isolates did not show
biofilm formation capability (Figure 1).
3.2. Prevalence of AFGs
Prevalence of different AFGs among UPEC isolates was
investigated and high prevalence (more than 50%) was
observed for fimA, fimH, papEF, and papC. According to
the results, papC was the most prevalent AFG among all
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Table 1. PCR primers for each adhesion factor gene.
Gene

Primers (5’→3’)

Size of product (bp)

Reference

fimH

F: TGCAGAACGGATAAGCCGTGG
R: GCAGTCACCTGCCCTCCGGTA

508

(21)

fimA

F: GTTGTTCTGTCGGTCGGCTCTGCT
R: ATGGTGTTGGTTCCGTTATTC

447

(19)

papEF

F: GCAACAGCAACGCTGGTTGCATCAT
R: AGAGAGAGCCACTCTTATAGGACA

336

(21)

papC

F: GTGGCAGTATGATGAATGACCGTTA
R: ATATCCTTTCTGCAGGGATGCAATA

200

(21)

papAH

F: ATGGCAGTGGTGTCTTTTGGTG
R: CGTCCCACCATACGTGCTCTCTTC

720

(22)

sfaS

F: GTGGATACGACGATTACTGTG
R: CCGCCAGCATTCCCTGTATTC

244

(22)

bmaE

F: ATGGCGCTAACTTGCCATGCTG
R: AGGGGGACATATAGCCCCTTC

507

(21)

foc/G

F: CAGCACAGGCAGTGGATACGA
R: GAATGTCGCCTGCCCATTGCT

364

(22)

Table 2. PCR conditions for each adhesion factor gene.
Gene

Initial denaturation
(°C/min)

Denaturation
(°C/s)

Annealing
(°C/s)

Extension
(°C/s)

Final extension
(°C/min)

Cycles

fimH

95/4

94/30

54/60

72/60

72/8

35

fimA

95/4

94/30

55/45

72/45

72/8

35

papEF

95/4

94/30

55/30

72/60

72/8

35

papC

95/4

94/30

60/55

72/45

72/8

33

papAH

95/4

94/30

60/45

72/60

72/8

33

sfaSa

95/4

94/30

60/45

72/60

72/8

33

bmaE

95/4

94/30

60/45

72/60

72/8

33

foc/Gb

95/4

94/30

60/45

72/60

72/8

33

b

a

a&b

gene amplification was performed using multiplex-PCR.

isolates (92%) followed by fimH, papEF, and fimA with
prevalence of 86%, 86%, and 76%, respectively. Moderate
prevalence for papAH and sfaS (42% for both genes) was
observed while low prevalence was recorded for foc/G
(20%) and bmaE (17%) (Figure 2; Table 3).
3.3. Association between AFGs and biofilm formation
ability
Distribution of different AFGs among UPEC isolates
according on their biofilm formation capability was
determined. In order to evaluate the association between
biofilm formation ability and AFGs, isolated UPECs were
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classified into two groups, including group Ι (no or weak
biofilm producers) and group II (moderate to strong
biofilm producers). According to the results, prevalence
of fimH among biofilm producing groups I and II were
87% and 86%, respectively, which was not significantly
different (P = 0.605). In addition, no significant difference
was observed for fimA (P = 0.253), papEF (P = 0.166),
papC (P = 0.198), or foc/G (P = 0.419). In contrast, higher
prevalence of sfaS and bmaE was recorded for the strains
able to produce moderate to strong biofilm (50% and
20%, respectively) while no strain belonging to the group
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Figure 1. Biofilm formation ability of UPEC isolates in microtiter
plate after staining with crystal violet.

Ι harbored the mentioned genes. In addition, papAH
was significantly more prevalent among group II strains
compared to group Ι (P = 0.040). The median of AFG
scores for groups Ι and II were 3 and 4, respectively, and no
strain harbored all AFGs. Table 3 presents the distribution
of different AFGs among isolated UPEC considering their
biofilm production ability.
3.4. Phenotypic expression of type 1 and P fimbriae
Phenotypic expression of type 1 and P fimbriae was
monitored by agglutination assays. According to the
results, 74% (62 out of 86) of the group II biofilm forming
UPEC expressed type 1 fimbriae, which was significantly
higher than the strains with poor biofilm formation ability
(44%). In addition, evaluation of phenotypic expression
the P fimbria showed no significant difference between
different biofilm-producing groups (69% for group Ι
versus 76% for group II strains).
4. Discussion
A better understanding of microbial pathogenesis would
facilitate the development of new therapeutic strategies.
The present study was conducted to elucidate the possible
association between different AFGs with biofilm formation
among UPEC strains isolated from UTIs. Ability to adhere
to different surfaces and biofilm formation have been
highlighted as important features associated with E. coli
virulence (3,4).
Surface virulence factors of the pathogens including
different adhesion factors may promote bacterial adhesion
and biofilm development (12). Our study indicated that

the majority of UPEC isolates were moderate to strong
biofilm producers (84%), while the remaining isolates
either did not produce biofilm or showed weak biofilm
formation potential. Thus, biofilm formation could
be considered an important virulence determinant
possessed by UPEC. Association of biofilm formation
ability and UTIs has been reported previously (13,14).
Biofilm formation promotes bacterial persistence in the
urinary tract by protecting bacteria from the clearing
out effect of hydrodynamic forces, antibacterial agents,
and host defense mechanisms. Evaluation of the factors
contributing to biofilm formation could be helpful
to conceive new therapeutic solutions to treat these
infections.
We found that the UPEC isolates able to form a
moderate to strong biofilm had a higher prevalence of
three AFGs, indicating that these adhesion factors may
play a role in biofilm development. Evaluation of the
prevalence of several AFGs among UPEC isolates showed
that the majority of the isolates harbored P and type 1
fimbriae associated genes (except for papAH), regardless
of their biofilm formation capability. High prevalence
of type 1 and P fimbriae associated genes among UPEC
strains was reported previously (15,16).
Association between a higher biofilm formation
potential and some virulence genes including P and type 1
fimbriae genes was reported earlier (15,17). However, no
significant association was observed between prevalence
of fimA, fimH, papC, and papEF and biofilm formation
potential in our study. Five genes of pap operon were
screened and only the papAH gene was significantly
associated with biofilm formation. This finding suggests
the unequal importance of P fimbria associated genes in
biofilm formation. However, further studies will need to
be done to interpret the significance of this finding.
In addition, our findings suggest that although type
1 and P fimbriae are important adhesion factors for
bacterial initial attachment to the biological surfaces
presence of the mentioned genes are not the only
determinant for biofilm development in UPEC strains
and several environmental and genetic factors may be
involved with expression of these genes (18). Similarly,
Fattahi et al. (19), in a study on E. coli strains causing
UTIs from northwest Iran, found no correlation between

Figure 2. Agarose gel electrophoretic detection of some VFGs among UPEC strains.
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Table 3. Distribution of different adhesion factor genes among UPEC isolates.
Prevalence of bacterial AFGs
Adhesion factor genes
(AFGs)

Group Ιa
n =16

Group ΙΙa
n = 84

Total
n = 100

P values

fimH

14 (87%)

72 (86%)

86

0.605

fimA

12 (75%)

64 (76%)

76

0.253

papEF

12 (75%)

74 (88%)

86

0.166

papC

16 (100%)

76 (90%)

92

0.198

sfaS*

0 (0%)

42 (50%)

42

0.002

bmaE*

0 (0%)

17 (20%)

17

0.04

foc/G

2 (13%)

18 (21%)

20

0.419

papAH*

3 (19%)

39 (46%)

42

0.040

Aggregate AFG score median (range)

3 (2–6)

4 (3–7)

4

0.003

Phenotypic expression
Type 1 fimbriae*

7 (44%)

62 (74%)

86

0.022

P fimbriae

11 (69%)

64 (76%)

75

0.529

*shows significance at 95% confidence.
a
Group Ι includes no or weak biofilm producers and group II contains moderate to strong biofilm producers.

presence of fimA and biofilm formation. However, they
reported that biofilm formation ability was associated
with presence of papC.
Phenotypic detection of type 1 fimbria among different
biofilm-producing groups was significantly different. The
isolates with moderate to strong biofilm formation ability
showed higher type 1 fimbria expression level compared
to the bacteria with poor biofilm formation potential. This
finding indicates that phenotypic expression of the type 1
fimbria is an important determinant in biofilm formation
by UPEC (13,20). Soto et al. (13) reported that
expression of the type 1 fimbria is independently
associated with biofilm formation, which was in accordance
with our data. Expression of type 1 fimbria could be
influenced by several factors including environmental
factors and genetic background of the isolates. Several
environmental factors and bacterial phylogenetic group
and host associated factors could regulate bacterial gene
expression and thus result in different genotypic and
phenotypic characteristics of UPEC strains (13).
Prevalence of P fimbria associated genes among two
biofilm-forming groups was not significantly different.
However, papAH was more prevalent among biofilmproducing UPEC isolates. In addition, phenotypic
detection of P fimbria did not show significant difference
either, indicating a less important role of P fimbria in
biofilm development in UTIs.
Prevalence of F1C and S fimbriae genes was also
investigated in this study. Our results showed that the F1C
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gene (foc/G) was not significantly different among the two
biofilm-producing groups, while S fimbria-associated gene
(sfaS) was significantly more prevalent among moderate
to strong biofilm producers. In fact, no isolate belonging
to group Ι harbored sfaS, while 42 isolates able to form
moderate to strong biofilm contained the gene. This finding
suggests strong association between S fimbria associated
gene and biofilm formation ability among UPEC. S fimbria
is a surface virulence factor with good binding efficacy to
epithelial and endothelial cell lines derived from the lower
human urinary tract and kidney and thus could be regarded
as a determinant factor in biofilm formation by UPEC (1).
In addition, the M fimbria gene (bmaE) was another AFG
that showed a significant difference among the two biofilmproducing groups. In this study, bmaE was not detected
in the strains with poor biofilm formation ability while
20% of the strains with good biofilm formation potential
harbored the M fimbria associated gene. Thus, although
the M fimbria gene was not highly prevalent among UPEC
isolates, it could be regarded as another determinant gene
in biofilm formation by UPEC.
Association of the aggregate virulence factor genes
score (including many AFGs) and pathogenicity of UPEC
has been investigated previously (13). Similarly, we found
that UPEC isolates able to form moderate to strong biofilm
had a higher median aggregate AFG score than those with
poor biofilm formation ability.
Biofilm formation of UPEC is a major determinant
in establishment of UTIs. In this study, we evaluated
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the biofilm formation potential of UPEC isolates and
introduced the association of sfaS, papAH, and bmaE
genes with biofilm formation capability. AFGs associated
with biofilm could be targets for prevention and treatment

of UPEC-associated UTIs. Future studies must explore the
function and expression level of the AFGs involved with
biofilm and associate them with the genetic background
of UPEC and also development of different types of UTIs.
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